Patrick Vink - 15 Jun 2022 Form 4 Insider Report for SQZ Biotechnologies Co (SQZB)

Role
Director
Signature
/s/ Lawrence Knopf, Attorney-in-Fact for Patrick Vink
Issuer symbol
SQZB
Transactions as of
15 Jun 2022
Transactions value $
$0
Form type
4
Filing time
16 Jun 2022, 17:00:50
Previous filing
07 Jan 2022
Next filing
19 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SQZB Stock Option Award $0 +20K $0.00 20K 15 Jun 2022 Common Stock 20K $3.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and become exercisable on the earlier of (i) June 15, 2023 or (ii) the day immediately prior to the date of the next annual meeting of stockholders following the date of grant, in each case subject to the recipient's continued service on the Board at such time.